38.22
-3.09%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Canmax Technologies Co
Its shares trade on Shenzhen under the ticker 300390.SZ. It has been listed since 31 July 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.54bn and net income of CN¥402.2m. At that date it held total assets of CN¥23.09bn and shareholders' equity of CN¥11.35bn.
Canmax Technologies Co., Ltd. engages in the manufacture and sale of cleanroom and electrostatic discharge (ESD) control products. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2014-07-31. The firm operates its business through three segments. Anti-static Ultra-clean Product segment provides anti-static ultra-clean products, including human body protection systems, process protection systems and environmental protection systems. Medical Device Product segment provides self-destruction syringes, safety syringes and high pressure syringes. Lithium Battery Material Product segment is mainly engaged in the research and development, production and sales of battery-grade lithium hydroxide. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 31 Jul 2014
- Employees
- 2,931
- Website
- canmax.com.cn ↗
Leadership
Pay as last reported
- Mr. Zhenhua PeiChairman of the Board, since 2007CN¥1.7m
- Mr. Deguang LiuPresidentCN¥862,000
- Mr. Jianping LuExecutive Vice Chairman of the Board, since 2007CN¥1.7m
- Mr. Chao YuanChief Financial OfficerCN¥700,000
- Ms. Heng WangVice President, DirectorCN¥1.5m
- Mr. Zhiyun XuVice President, since 2019CN¥1.1m
- Mr. Xun WangSecretary of the BoardCN¥500,000
- Mr. Yunchao FeiDirectorCN¥182,000
- Mr. Juming GongIndependent DirectorCN¥120,000
- Mr. Xuexian HuangIndependent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 62
- Environment
- 87
- Social
- 38
- Governance
- 61
- Direct emissions (scope 1)
- 277,098.65 t
- Energy emissions (scope 2)
- 206,138.66 t
- Women in the workforce
- 32.67275%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company employs 2,931 full-time staff members in Suzhou.
- The Anti-static Ultra-clean Product segment provides human body protection systems.
- The Medical Device Product segment offers self-destruction syringes to customers.
Weaknesses
- The firm operates through three distinct business segments.
- The company went public on 31 July 2014 via IPO.
- The Lithium Battery Material segment focuses on battery-grade lithium hydroxide.
Opportunities
- The firm distributes its products in the domestic market.
- The company sells its goods to overseas markets globally.
- The Lithium Battery Material segment engages in research and development.
Threats
- The Anti-static Ultra-clean Product segment includes process protection systems.
- The Medical Device Product segment provides safety syringes for use.
- The Lithium Battery Material segment handles production and sales.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.